Actavis Generics' Unit Acquisition

Actavis Generics raised a round of funding on July 27, 2016. Investors include Teva Pharmaceuticals.

Actavis Generics is a global pharmaceutical company focused on developing, manufacturing, and commercializing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Ac…

Articles about Actavis Generics' Unit Acquisition: